Table 2 Concordance between Genotype MTBDRsl and Bactec MGIT-960 based second-line drug susceptibility testing.
Genotype MTBDR sl | SLD by Bactec MGIT 960 | |||||
|---|---|---|---|---|---|---|
Sensitive (%) | FQ mono-resistant (%) | AG/CP mono-resistant (%) | XDR (%) | Concordance (%) | k coeff | |
Sensitive (232) (64.6%) | 225 (97) | 7(3.0) | — | — | 97 | 0.92 Perfect |
FQ- resistant (108) (30%) | 6(5.5) | 101 (93.5) | — | 1(0.9) | 93.5 | 0.89 Perfect |
AG/CP- resistant (2) (0.5%) | — | 1(50) | 1 (50) | — | 50 | 0.66 Substantial |
XDR (17) (4.7%) | — | 1(5.9) | — | 16(94.1) | 94.1 | 0.93 Perfect |
Total (359) | 231 (64.4) | 110 (30.6) | 1 (0.3) | 17 (4.7) | — |  |